Clinical Trial Update: Study of COPD Subgroups and Biomarkers

View source ↗

Summary

A clinical trial update indicates an active-not-recruiting study on COPD subgroups and biomarkers run by University of North Carolina at Chapel Hill.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: COPD, Chronic Obstructive Pulmonary Disease | Status: ACTIVE_NOT_RECRUITING